BON Announces Launch of Tea Pigment Digestive Health Products and Cooperation Agreement Signed with Shanghai Risesun International Trade
Bon Natural Life Limited (BON) has announced a non-exclusive sales cooperation agreement with Shanghai Risesun International Trade for marketing and distributing BON's tea pigment series health products in China. The agreement spans 24 months with a total contract value of $24 million.
The company's tea pigments, which offer benefits in lipid modulation, glycemic control, antioxidant activity, and anti-peptic ulcer properties, are targeting the digestive wellness and blood glucose regulation markets. With strong market fundamentals and global tea popularity, the venture has potential to reach a $1 billion market valuation.
Bon Natural Life Limited (BON) ha annunciato un accordo di cooperazione commerciale non esclusivo con Shanghai Risesun International Trade per la commercializzazione e distribuzione dei prodotti salutistici a base di pigmenti del tè di BON in Cina. L'accordo ha una durata di 24 mesi e un valore contrattuale totale di 24 milioni di dollari.
I pigmenti del tè dell'azienda, che offrono benefici nella modulazione dei lipidi, nel controllo glicemico, nell'attività antiossidante e nelle proprietà antiulcera peptica, sono destinati ai mercati del benessere digestivo e della regolazione della glicemia. Grazie a solidi fondamentali di mercato e alla popolarità globale del tè, l'iniziativa ha il potenziale per raggiungere una valutazione di mercato di 1 miliardo di dollari.
Bon Natural Life Limited (BON) ha anunciado un acuerdo de cooperación comercial no exclusivo con Shanghai Risesun International Trade para la comercialización y distribución de la serie de productos saludables de pigmentos de té de BON en China. El acuerdo tiene una duración de 24 meses y un valor total de contrato de 24 millones de dólares.
Los pigmentos de té de la empresa, que ofrecen beneficios en la modulación de lípidos, control glucémico, actividad antioxidante y propiedades antiúlceras pépticas, están dirigidos a los mercados de bienestar digestivo y regulación de glucosa en sangre. Con sólidos fundamentos de mercado y la popularidad global del té, el proyecto tiene el potencial de alcanzar una valoración de mercado de 1.000 millones de dólares.
본 내추럴 라이프 리미티드(BON)는 상하이 라이즈선 인터내셔널 트레이드와 비독점 판매 협력 계약을 체결하여 중국 내 BON의 차 색소 시리즈 건강 제품의 마케팅 및 유통을 담당하게 되었습니다. 이 계약은 24개월간 유효하며 총 계약 금액은 2,400만 달러입니다.
회사의 차 색소 제품은 지질 조절, 혈당 관리, 항산화 활성 및 소화성 궤양 예방 효과를 제공하며, 소화 건강과 혈당 조절 시장을 목표로 하고 있습니다. 견고한 시장 기반과 전 세계적인 차의 인기 덕분에 이 사업은 10억 달러 시장 가치에 도달할 잠재력을 가지고 있습니다.
Bon Natural Life Limited (BON) a annoncé un accord de coopération commerciale non exclusif avec Shanghai Risesun International Trade pour la commercialisation et la distribution de la gamme de produits santé à base de pigments de thé de BON en Chine. L'accord s'étend sur 24 mois avec une valeur contractuelle totale de 24 millions de dollars.
Les pigments de thé de l'entreprise, qui offrent des bénéfices en modulation des lipides, contrôle glycémique, activité antioxydante et propriétés anti-ulcéreuses, ciblent les marchés du bien-être digestif et de la régulation de la glycémie. Avec des fondamentaux solides et la popularité mondiale du thé, ce projet a le potentiel d'atteindre une valorisation de marché d'un milliard de dollars.
Bon Natural Life Limited (BON) hat eine nicht-exklusive Vertriebspartnerschaft mit Shanghai Risesun International Trade geschlossen, um BONs Tee-Pigment-Serie von Gesundheitsprodukten in China zu vermarkten und zu vertreiben. Der Vertrag läuft über 24 Monate mit einem Gesamtwert von 24 Millionen US-Dollar.
Die Tee-Pigmente des Unternehmens, die Vorteile bei der Lipidmodulation, Blutzuckerkontrolle, antioxidativer Aktivität und anti-peptischen Ulzereigenschaften bieten, zielen auf die Märkte für Verdauungsgesundheit und Blutzuckerregulierung ab. Mit soliden Marktgrundlagen und der weltweiten Beliebtheit von Tee hat das Vorhaben das Potenzial, eine Marktbewertung von 1 Milliarde US-Dollar zu erreichen.
- 24-month agreement worth $24 million signed with Shanghai Risesun for product distribution
- Product has potential to reach $1 billion market valuation
- Multiple health benefits identified for tea pigments including digestive wellness and blood glucose regulation
- Strong market fundamentals backed by global tea popularity and ample raw material supply
- Non-exclusive agreement limits market protection
- Market valuation projection of $1 billion is speculative and not guaranteed
Insights
BON's $24M tea pigment deal with Shanghai Risesun targets billion-dollar digestive health market, diversifying revenue streams.
BON's strategic partnership with Shanghai Risesun represents a calculated market entry into the rapidly expanding digestive wellness sector. The $24 million non-exclusive agreement over 24 months provides BON with a dedicated distribution channel while preserving flexibility to pursue additional partnerships.
The company's focus on tea pigments as bioactive compounds is particularly noteworthy. These phytochemicals offer a multi-mechanism approach to health, addressing lipid profiles, glycemic control, antioxidant activity, and anti-peptic ulcer properties – positioning them as versatile ingredients for various digestive applications. This creates significant cross-category potential beyond the initial digestive health focus.
What's compelling about BON's approach is the supply chain stability. By leveraging tea – one of the world's most consumed beverages with established agricultural infrastructure – they've mitigated the supply constraints that often plague novel ingredient commercialization. This fundamentally de-risks scaling operations compared to ingredients dependent on rare botanicals or complex extraction processes.
The market positioning is strategic, filling the innovation gap between commodity tea extracts and pharmaceutical interventions. With digestive health representing a major consumer concern and blood glucose management becoming increasingly mainstream, BON is targeting high-growth segments with substantial consumer willingness-to-pay. The potential $1 billion market valuation cited, while ambitious, reflects the significant global demand for natural digestive health solutions.
XI’AN, China, May 22, 2025 (GLOBE NEWSWIRE) -- Bon Natural Life Limited (Nasdaq: BON) (“BON” or the “Company”), a leading bio-ingredient solution provider in the natural, health and personal care industry, today announced a non-exclusive sales cooperation agreement with Shanghai Risesun International Trade Co., Ltd., a leading functional ingredient distributor in China. The term of the Agreement is 24 months with a total contract value of US
Leveraging a robust biological profile that includes lipid modulation, glycemic control, antioxidant activity, and anti-peptic ulcer, tea pigments demonstrate broad applicability across multiple health sectors. This phytochemical complex now stands as one of the more promising functional tea derivatives since the commercialization of tea polyphenols, gaining particular traction in two high-demand sectors: digestive wellness and blood glucose regulation. Backed by an ample supply of tea raw materials and supported by tea’s global popularity as one of the largest beverage categories, this innovation is well-positioned for mass adoption. With robust consumer interest and strong market fundamentals, the venture could potentially exceed a
Hu Yongwei, CEO and Chairman of BON, commented: “This strategic collaboration with Shanghai Risesun capitalizes on core tea pigment technologies to help accelerate our entry into the high-growth digestive health sector. This transformative partnership marks a strategic milestone in advancing our health solutions business while expanding global commercialization of tea pigment-based products-positioning BON as a leader in this category. We anticipate this alliance will fuel revenue and earnings growth, and potentially elevate shareholder returns through sustainable market expansion.”
About Bon Natural Life Limited (“BON”)
BON is a Cayman Islands company engaged in the business of natural, health, and personal care industries. For more information, please visit the Company’s website at http://www.bnlus.com.
For more information, please contact:
Cindy Liu | IR
Email: bonnatural@appchem.cn
Safe Harbor Statement
This press release contains certain statements that may include “forward-looking statements.” All statements other than statements of historical fact included herein are “forward-looking statements.” These forward-looking statements are often identified by the use of forward-looking terminology such as “believes”, “expects” or similar expressions, involve known and unknown risks and uncertainties. Although the Company believes that the expectations reflected in such forward-looking statements are reasonable, they do involve assumptions, risks, and uncertainties, and these expectations may prove to be incorrect. You should not place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The Company’s actual results could differ materially from those anticipated in these forward-looking statements as a result of a variety of factors, including those discussed in the Company’s periodic reports that are filed with the Securities and Exchange Commission and available on its website (http://www.sec.gov). All forward-looking statements attributable to the Company or persons acting on its behalf are expressly qualified in their entirety by these factors. Other than as required under the securities laws, the Company does not assume a duty to update these forward-looking statements.
FAQ
What is the value and duration of BON's agreement with Shanghai Risesun?
What are the main health benefits of BON's tea pigment products?
What is the market potential for BON's tea pigment products?
Who will distribute BON's tea pigment products in China?
What type of agreement did BON sign with Shanghai Risesun?
